Skip to main content
. Author manuscript; available in PMC: 2021 May 15.
Published in final edited form as: Clin Cancer Res. 2020 Sep 14;26(22):6064–6074. doi: 10.1158/1078-0432.CCR-20-1682

Figure 2.

Figure 2.

STS inhibitor design and selection. A. VCaP cells were treated with 5 μM STS inhibitors overnight and STS activity was determined by STS fluorometric assay. B. C4–2B cells were treated with 2.5 μM of STS inhibitors for 3 days. Total cell numbers were determined. C. SI-1 and SI-2 chemical structures and molecular weight. * p<0.05.